Roche Holding
CHF 358.80Change from previous close: −0.55%Absolute change: −CHF 2.00
Valuation
Data as of October 1, 2026
Valuation multiples
- Market cap
- CHF 285.88B
- Enterprise value
- CHF 313.48B
- P/E (trailing 12 months)
- 23.4
- Forward P/E
- 16.3
- PEG
- 1.66
- Price/book
- 8.74
- Price/sales
- 4.54
- EV/EBITDA
- 13.1
- EV/revenue
- 4.98
Profitability and growth
- Gross margin
- 74.2%
- Operating margin
- 36.2%
- Net margin
- 19.6%
- ROE
- 38.1%
- ROA
- 13.5%
- Revenue growth (year over year)
- -1.2%
- Earnings growth (year over year)
- -7.7%
Financial health
- Total cash
- CHF 9.73B
- Total debt
- CHF 33.31B
- Debt/equity
- 0.91
- Current ratio
- 1.23
- Quick ratio
- 0.80
Dividends
- Annual dividend per share
- CHF 9.80
- Dividend yield
- 2.7%
- Payout ratio
- 63.9%
- Ex-dividend date
- March 12, 2026
Analysts and estimates
- Average price target
- CHF 368.00
- Median price target
- CHF 368.00
- High price target
- CHF 396.00
- Low price target
- CHF 340.00
- Analysts with a price target
- 2
- Forward EPS
- CHF 22.01
- EPS estimate, current year
- CHF 20.35
Shares and trading
- Beta
- 0.35
- Average volume
- 26.32K
- Shares outstanding
- 106.69M
- Float
- 654.09M
- Institutional ownership
- 11.0%
- Insider ownership
- 72.3%